Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
Clinical trial NCT00338117 · COMPLETED
Trial details
- NCT number
- NCT00338117
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-08-01
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.